✦ LIBER ✦

Increase of peripheral Th17 lymphocytes during acute cellular rejection in liver transplant recipients

✍ Scribed by Fan, Hua; Li, Li-Xin; Han, Dong-Dong; Kou, Jian-Tao; Li, Ping; He, Qiang

Book ID: 123469633
Publisher: Zhejiang University School of Medicine, China
Year: 2012
Tongue: English
Weight: 442 KB
Volume: 11
Category: Article
ISSN: 1499-3872
DOI: 10.1016/S1499-3872(12)60231-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of non-cellular acute rejectio

Incidence of non-cellular acute rejection in heart transplant recipients

✍ J.P. Naour; K. Malinowska; B.A. Pisani; J.C. Mendez; R.C. Lichtenberg; J.A. Robi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Incidence of Acute Rejection in African-

Incidence of Acute Rejection in African-American Liver Transplant Recipients

✍ M Maggard; J Goss; S Ramdev; K Swenson; R.W Busuttil 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Guanylate-binding protein 2 mRNA in peri

Guanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejection

✍ Shogo Kobayashi; Hiroaki Nagano; Shigeru Marubashi; Naoki Hama; Tadafumi Asaoka; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 315 KB

Interleukin 2 production by peripheral b

Interleukin 2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes

✍ Vie, Henri; Bonneville, Marc; Cariou, Roger; François Moreau, Jean; Soulillou, J 📂 Article 📅 1985 🏛 Nature Publishing Group 🌐 English ⚖ 441 KB

Soluble T lymphocyte markers in the diag

Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipients

✍ Dora I. Ninova; Russell H. Wiesner; Gregory J. Gores; Jay M. Harrison; Ruud A.F. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Outcomes of acute rejection after interf

Outcomes of acute rejection after interferon therapy in liver transplant recipients

✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir